DOXOrubicin Hydrochloride (Amneal-Agila, LLC)
Welcome to the PulseAid listing for the DOXOrubicin Hydrochloride drug offered from Amneal-Agila, LLC. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Amneal-Agila, LLC |
NON-PROPRIETARY NAME: | DOXOrubicin Hydrochloride |
SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-04-30 |
END MARKETING DATE: | 0000-00-00 |
DOXOrubicin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | DOXOrubicin Hydrochloride from Amneal-Agila, LLC |
LABELER NAME: | Amneal-Agila, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/10mL) |
START MARKETING DATE: | 2013-04-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53150-314_7e9e34a5-0865-4193-aa65-41a7b87821dc |
PRODUCT NDC: | 53150-314 |
APPLICATION NUMBER: | ANDA200901 |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: